TRAF-STOP therapy with either SMI 6860766 or 6877002 decreased the onset of early atherosclerosis and stopped the progression of established atherosclerosis in ApoE−/− mice (Seijkens et al., 2018). This evidence concerns the gene MAP6 and atherosclerosis.